Multidrug-resistant Acinetobacter baumannii isolates in pediatric patients of a university hospital in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 40, Issue 5, 2007, Pages 406-410

  Chang, Po Yang ^a   Hsueh, Po Ren ^b   Wu, Ping Sheng ^b   Chan, Pei Chun ^b   Yang, Tsao Ton ^b   Lu, Chun Yi ^b   Chang, Luan Yin ^b   Chen, Jung Min ^b   Lee, Ping Ing ^b   Lee, Chin Yun ^b   Huang, Li Min ^b  

^a CHANG BING SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acinetobacter baumannii; Drug resistance, multiple, bacterial; Pediatrics

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; AZTREONAM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MACROLIDE; MEROPENEM; MINOCYCLINE; OFLOXACIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; SULTAMICILLIN; TIMENTIN;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CANCER CHEMOTHERAPY; CHILD; CHILD CARE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HOST RESISTANCE; HUMAN; INFANT; INTENSIVE CARE; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MORTALITY; MULTIDRUG RESISTANCE; NEOPLASM; NEUROLOGIC DISEASE; NEUTROPENIA; NEWBORN; NEWBORN DISEASE; OUTCOME ASSESSMENT; PATHOGENESIS; PERINEUM; PERITONITIS; PNEUMONIA; SEPSIS; TAIWAN; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; VENTILATOR; WOUND INFECTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; MALE; PERINEUM; PERITONITIS; PNEUMONIA; RISK FACTORS; SEPSIS; TAIWAN; URINARY TRACT INFECTIONS; WOUND INFECTION;

EID: 38049058936     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cisneros JM, Rodríguez-Baño J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002;8:687-93.
2. Hsueh PR, Liu YC, Yang D, Yan JJ, Wu TL, Huang WK, et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist. 2001;7:373-82.
3. Go ES, Urban C, Burns J, Kreiswirth B, Eisner W, Mariano N, et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet. 1994;344:1329-32.
4. Corbella X, Montero A, Pujol M, Domínguez MA, Ayats J, Argerich MJ, et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol. 2000; 38:4086-95.
5. López-Hernandez S, Alarcón T, López-Brea M. Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain. Eur J Clin Microbiol Infect Dis. 1998;17:282-5.
6. Tankovic J, Legrand P, De Gatines G, Chemineau V, Brun-Buisson C, Duval J. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J Clin Microbiol. 1994;32: 2677-81.
7. Bou G, Cerveró G, Domínguez MA, Quereda C, Martínez-Beltrán J. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J Clin Microbiol. 2000;38:3299-305.
8. Hsueh PR, Teng LJ, Chen CY, Chen WH, Yu CJ, Ho SW, et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis. 2002;8:827-32.
9. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk susceptibility tests. Approved standard, 9th Ed. CLSI document M2-A9. Wayne, PA: Clinical and Laboratory Standards Institute; 2006.
10. Wang SH, Sheng WH, Chang YY, Wang LH, Lin HC, Chen ML, et al. Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit. J Hosp Infect. 2003;53:97-102.
11. Mahgoub S, Ahmed J, Glatt AE. Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii. Am J Infect Control. 2002;30:386-90.
12. Kuo LC, Yu CJ, Lee LN, Wang JL, Wang HC, Hsueh PR, et al. Clinical features of pandrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Taiwan. J Formos Med Assoc. 2003;102:601-6.
13. Lai SW, Ng KC, Yu WL, Liu CS, Lai MM, Lin CC. Acinetobacter baumannii bloodstream infection: clinical features and antimicrobial susceptibilities of isolates. Kaohsiung J Med Sci. 1999;15:406-13.
14. Bernabeu-Wittel M, Pichardo C, García-Curiel A, Pachón-Ibáñez ME, Ibáñez-Martínez J, Jiménez-Mejías ME, et al. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia. Clin Microbiol Infect. 2005;11: 319-25.
15. Aubert G, Guichard D, Vedel G. In-vitro activity of cephalosporins alone and combined with sulbactam against various strains of Acinetobacter baumannii with different antibiotic resistance profiles. J Antimicrob Chemother. 1996;37: 155-60.
16. Corbella X, Ariza J, Ardanuy C, Vuelta M, Tubau F, Sora M, et al. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother. 1998;42: 793-802.
17. Lee CM, Lim HK, Liu CP, Tseng HK. Treatment of pan-drug resistant Acinetobacter baumannii. Scand J Infect Dis. 2005; 37:195-9.